The Start

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-03T15:57:25.237Z • Permanent link

Medical aid in dying, also known as physician-assisted dying or end-of-life care, has been a contentious issue for decades. However, with the recent legalization of medical aid in dying in New York, a team of clinical professionals has taken a bold step towards providing a new option for patients facing terminal illnesses. Led by Dr. Megan Moreno, a renowned physician and palliative care specialist, the team has created a practice that aims to help patients die on their own terms.

The practice, which is based in New York City, was established in partnership with Compassion & Choices, a national organization that advocates for patients' rights to control their own end-of-life care. The team of clinical professionals, which includes nurses, social workers, and spiritual care specialists, provides comprehensive care to patients who have been diagnosed with a terminal illness and have less than six months to live. The team works closely with patients to understand their values, goals, and wishes, and then helps them navigate the medical and social complexities of end-of-life care.

The decision to create this practice was driven by a desire to address the growing need for end-of-life care in the United States. According to the National Hospice and Palliative Care Organization, there are over 1.5 million Americans who are living with terminal illnesses, and yet, many patients and families are not receiving the care and support they need. Dr. Moreno and her team aim to change this by providing a safe, compassionate, and dignified option for patients who want to die on their own terms.

The legalization of medical aid in dying in New York has significant implications for the Data Sources domain. Companies that provide data analytics and insights to healthcare providers and research institutions will need to adapt to this new reality. For example, companies like Optum and UnitedHealthcare, which provide data analytics services to healthcare providers, will need to develop new models to help providers navigate the complexities of end-of-life care. Research communities, such as those focused on palliative care and end-of-life medicine, will also need to adapt to this new reality, as they seek to understand the impact of medical aid in dying on patient outcomes and quality of life.

The impact of medical aid in dying on markets and policy environments will also be significant. For example, companies like CVS Health and Walgreens, which have already begun to offer end-of-life care services, will need to continue to innovate and improve their services to meet the growing demand for these services. Policy makers will also need to adapt to this new reality, as they seek to balance the need to protect vulnerable populations with the need to provide patients with options for end-of-life care.

The legalization of medical aid in dying in New York is part of a larger pattern of increasing recognition of the need for end-of-life care in the United States. In recent years, several states have passed laws allowing patients to access medical aid in dying, and there are growing calls for federal policy makers to take action to address this issue. This trend is also part of a broader shift towards greater recognition of the need for patient-centered care, which prioritizes patients' values, goals, and wishes in decision-making.